$Palantir Technologies Inc.(PLTR)$ $Direxion Daily PLTR Bull 2X Shares(PLTU)$ π‘οΈππ₯ Palantir Q2: Safe AI, Strategic AI, and the $10B Signal π₯ππ‘οΈ
Iβm extremely confident that Palantirβs Q2 earnings on 04Aug25 EST / 05Aug25 NZT will deliver more than just numbers. This is a defining moment in the battle between scaling AI and safe AI, and $PLTR is uniquely positioned at that intersection.
The company has already captured headlines with a $10 billion, 10-year U.S. Army contract; its largest ever; consolidating 75 existing agreements and streamlining procurement across the Department of Defense. This deal validates Palantir not just as a supplier, but as standard infrastructure. Earnings will now determine whether AIP can commercialise at the scale and velocity required to justify one of the marketβs most aggressive AI valuations.
Q2 Bloomberg consensus expects $940M in revenue (+38.6% YoY), $357M in adjusted net profit (+61.3%), and $0.139 in adjusted EPS (+55%). The company previously guided to $934Mβ$938M in revenue, suggesting a beat remains within reach. Guidance for FY25 stands at $3.89Bβ$3.90B in revenue, $1.711Bβ$1.723B in adjusted operating profit, and $1.6Bβ$1.8B in free cash flow.
Last quarter, Palantir delivered $884M in revenue (+39% YoY), beating estimates of $863M. EPS came in at $0.13, with a sharp rise in operating margin to 19.9% (from 12.8%). Net income doubled to $214M, adjusted free cash flow surged to $370M, and the company ended the quarter with $5.4B in cash and zero debt. U.S. government revenue grew 45% to $373M. Commercial business was the real standout, up 71% YoY to $255M. Remaining Performance Obligations (RPO) reached $1.9B. Anything above $2.15B this quarter would reinforce growth momentum. Below $2.05B would be a red flag.
AIPβs commercialisation is now the focal point. The platform is deployed in over 100 institutions, with more than 300 companies in active negotiation. This quarter, the market is watching to see if customers are moving from technical pilots to full platform subscriptions. These deals, once locked in, create recurring, high-quality revenue. In parallel, the company is expanding its βdeep-bindingβ delivery model, embedding on-site technical teams to drive use-case scale in logistics, healthcare, energy, and manufacturing. The key question is whether Palantir can replicate this strategy in Europe and Asia, where commercial expansion remains under-penetrated.
While OpenAI and Anthropic dominate headlines, Palantirβs AIP sits in a unique lane. According to the Future of Life Institute, only Anthropicβs Claude earned a C+ safety grade. OpenAI, Meta, DeepMind, and others scored D or F, particularly in existential risk and governance. Palantir wasnβt rated, but it behaves more like Claude than ChatGPT. Its architecture is built around auditability, explainability, and deployment inside mission-critical institutions. Thatβs what the Pentagon buys, not benchmark scores.
Speaking of benchmarks, OpenAIβs latest Q3 model leads on the Mensa IQ scale at 135, followed by Claude-4 Sonnet at 127, and DeepSeek R1 at 106. But high IQ doesnβt win defense contracts. Palantirβs advantage isnβt general intelligence; itβs strategic integration. Whether youβre the Army forecasting battlefield scenarios or a Fortune 100 firm optimizing complex workflows, PLTR delivers applied, interpretable results. Itβs built for command decisions, not consumer interfaces.
AIβs productivity advantage is another driver. According to Stanford and the World Bank, generative AI can reduce task times by 60% or more. Writing drops from 80 minutes to 25. System analysis: from 87 minutes to 31. AIP is delivering those results across use cases. Time saved becomes margin captured, and margin powers recurring revenue. This is how Palantir wins the monetisation game without relying on advertising models or chatbot virality.
That said, valuation is lofty. Palantir trades at over 20Γ EV/Sales, a P/E of roughly 700, and a forward P/E near 270. Bulls argue this is justified by its rare high-growth plus high-margin model, its Nasdaq 100 inclusion, and its streak of quarterly beats. Bears warn that any guidance slip could bring compression.
Technical setup shows price at $155.16, consolidating just above the 55 EMA on the 4H. Support is around $152.00. Earnings resistance lies at $158.70β$160.10. On a strong beat and guide, price could accelerate toward $173.20 and $185.60. A miss, especially on RPO or AIP conversion, risks breaking below $148.
Analysts remain divided. Wedbushβs Dan Ives sees Palantir as the βAWS of AI,β with a $160 price target. Piper Sandler goes further, assigning a $175 PT on the assumption that Palantir hits $24B in revenue by 2032, maintaining over 30% CAGR and over 40% free cash flow margin. Morgan Stanley remains cautious, citing risk from commercial AI competition like C3.ai and Snowflake, and concern over how quickly AIP adoption can scale.
ETF exposure is meaningful. $BOTZ and $ARKQ both hold Palantir. Indirect AI exposure can also be played via $MSFT (OpenAI), $GOOGL (Anthropic, Claude), and AI hardware backbones like $NVDA and $SMCI.
Palantir is not a speculative AI bet. It is becoming operational infrastructure across defense and enterprise. The $10B Army deal isnβt just revenue; itβs validation. If Q2 confirms the growth in backlog, commercial conversion, and AIP margin leverage, this premium holds. If not, the multiple has nowhere to hide.
π’ Donβt miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets ππ Iβm obsessed with hunting down the next big movers and sharing strategies that crush it. Letβs outsmart the market and stack those gains together! π
Trade like a boss! Happy trading ahead, Cheers, BC πππππ
@Tiger_comments @TigerPicks @TigerStars @TigerWire @TigerObserver @Tiger_Earnings @1PC
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Great article, would you like to share it?